Neuroblastoma

High-risk tumors were enriched for translational and ribosome biogenesis pathways, whereas low-risk tumors were enriched for adaptive immune activation programs. Cross-context transcriptomic integration identified a minimal ALK-associated three-gene signature that reproducibly predicts NB outcomes and reflects distinct underlying biological states, supporting its potential value for risk stratification and hypothesis-driven therapeutic development.

Collectively, our findings uncover a novel mechanism by which doxorubicin enhances NB tumor susceptibility to γδT-cell-mediated killing through ULBP1 up-regulation. This study provides a strong rationale for combining chemotherapy with γδT-cell-based immunotherapy to improve outcomes in high-risk NB patients.

Although the primary endpoint was not met, BA showed a manageable safety profile and a subset of patients derived clinical benefit with prolonged stable disease, including one patient with a complete metabolic response. This first clinical trial of systemic therapy in R/M ONB serves as proof of clinical trials feasibility in this setting and supports further investigation of combinatorial immunotherapy strategies in this patient population. Trial registration ClinicalTrials.gov Identifier: NCT05012098, https://clinicaltrials.gov/ct2/show/NCT05012098. Registered 18 August 2021.

This signaling cascade suppresses NF-κB-mediated proinflammatory pathways, evidenced by diminished NF-κB activation and reduced secretion of inflammatory mediators (interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)), ultimately promoting SH-SY5Y survival. Our findings establish glycoRNAs as critical mediators of intercellular signaling with therapeutic potential in neuroinflammation.

P1, N=3, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Recruiting --> Active, not recruiting | N=23 --> 3

The boy was diagnosed with HS and additional diagnostic measures, including cancer screening, were ordered, owing to the syndrome's characteristics. Awareness of such conditions enables clinicians to implement targeted management that may significantly improve long-term outcomes and quality of life for affected children.

And siRNA-mediated VEGFR-1 knockdown in the mouse primary neurons, reduced gene expression of both the ISGs and oxidative stress/cell death pathways in response to Aβ1-42 oligomer treatment. In summary, these results show that siRNA-mediated knockdown of VEGFR-1 in neurons significantly prevented hypoxia, Aβ1-42 oligomer and Aβ1-42 fibril-induced cellular toxicities and cell death phenotypes, indicating a potential detrimental role of aberrant VEGFR-1 expression and signaling in response to AD associated pathologies.

Structure-based virtual screening identified several candidate inhibitors of NDUFS6, including guanosine 5'-triphosphate (disodium salt), 1,4-β-D-xylopentaose, and deferoxamine...NDUFS6 is significantly upregulated in HR-NB and contributes to tumor aggressiveness by promoting proliferation, migration, and invasion, accompanied by activation of metabolic pathways and suppression of neuronal differentiation and immune responses. Virtual screening identified guanosine 5'-triphosphate (disodium salt) as a potential NDUFS6 inhibitor with efficacy in both MYCN-amplified and non-amplified cells, highlighting NDUFS6 as a promising therapeutic target and providing a rationale for targeted intervention in HR-NB.

Importantly, these functional improvements occurred in the absence of dopamine restoration, although a restored dopamine metabolism, with reduced catabolic degradation (modulatory effect on 3,4-dihydroxyphenylacetic acid, DOPAC, production) was detected. In conclusion, neuroprotective and symptomatic effects were observed after HA-Tyr/Rosmarinus officinalis administration, supporting HA-Tyr hydrogels as promising mucoadhesive platform for intranasal delivery of neuroprotective compounds and bridging material innovation with translational potential.

Despite the powerful impact of SIRPA-KO on iMac antitumor activities in vitro, only modest efficacy was observed in human xenograft mouse models of SK-OV3 ovarian carcinoma and CHLA-163 neuroblastoma treated with mAb or CAR-iMac therapy, indicating further engineering or combinatorial therapeutic strategies are needed for potent in vivo antitumor efficacy. Together, these findings identify SIRPα as a regulator in macrophage hypophagia and underscore the advantages of using SIRPA-KO macrophage therapeutic strategies to modulate the SIRPα-CD47 checkpoint to unleash macrophage antitumor activity within the TME.

P2, N=122, Active, not recruiting, Y-mAbs Therapeutics | Recruiting --> Active, not recruiting

Furthermore, 45A overexpression leads to an increased number of abnormal spindles, thus promoting chromosomal instability and possibly explaining the increased tumorigenic potential exhibited by 45A-overexpressing cells. These data highlight the role of 45A ncRNA in the functional regulation of several proteins involved in microtubule dynamics, supporting its possible relevance in prognosis.